Ending the opioid epidemic requires addressing not only treatment gaps in addiction and overdose, but also inadequate pain management.
Academic rigor, journalistic flair
Articles on Health insurance
Displaying 41 - 60 of 137 articles
Two economists explain what insurers can and can’t do to factor vaccination status into their coverage and rates.
The FDA approved Alzheimer’s disease drug aducanumab despite minimal evidence of its efficacy. Whether this decision ultimately hurts or helps patients depends on data researchers don’t yet have.
Both are essential on a farm, but the costs are making it harder for young farmers to grow their businesses.
The US health system costs roughly twice as much as the Australian system per person. Despite this, the US has lower life expectancy than Australia.
Often the main differences among plans involve a long list of varying deductibles, co-pays and other out-of-pocket expenses, which can be tough to analyze.
New Zealanders have, in principle, access to free healthcare. But inequality is a major issue, affecting Māori and Pasifika communities and New Zealanders living with disabilities or in poverty.
For millions, the ACA is making a big difference during the coronavirus crisis.
COVID-19 cases among college students are inevitable. If you’re a college student – or the parent of one – you need to know who’s going to foot the bill if they get sick.
Studies repeatedly have shown that health care in general and the high cost of drugs in particular are among the top concerns of US voters. But with coronavirus, the issue may fade from prominence.
Help is out there for those many who have lost health insurance because of the pandemic. You can thank Obamacare.
COVID19 threatens to reverse years of Indonesia’s positive trends in poverty alleviation. We highlight lessons from past policies to prevent another poverty hike during the pandemic.
The pandemic magnifies existing imbalances in wealth, access to health care and workplace rights.
In the UK, nobody collects patients’ insurance information or credit card details. There’s simply no charge for services, including doctor visits, ambulances and hospitalizations.
Ghana’s lack of a palliative care policy is posing a significant challenge to effective healthcare for cancer patients.
It’s not the price of health care that should concern us. It’s the cost. There’s a distinction, and it matters. Here’s why.
High prescription drug costs are a widespread concern for consumers and policymakers. For patients who need specialty drugs, though, the problem is even worse, with no relief in sight.
In the wake of the New Deal, the business community realized that appealing to widely shared American values could get the public to oppose measures that curbed corporate power.
Young people don’t see the value in private health insurance and are dropping their cover in droves. Allowing under 55s to pay lower premiums, based on their lower risk, could keep them in the system.
Just how big a problem are medical bankruptcies? For someone going through one, it’s devastating. And it happens far more often than you might think.
Top contributors
-
Associate Professor of Public Health, Texas A&M University
-
Professor of Health Finance, Weatherhead School of Management & School of Medicine, Case Western Reserve University
-
Assistant Professor of Health Law, Policy and Management, Boston University
-
Research Assistant Professor of Social, Behavioral and Population Sciences, Tulane University
-
Research Scientist and Director of Research Training in Health Policy and Economics, University of Southern California
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Assistant Professor of Economics, University of California, Berkeley
-
Associate Professor of Health Policy, Management and Behavior, University at Albany, State University of New York
-
Professor, Public Health, Victoria University, Victoria University
-
Assistant professor of Health Policy & Administration, University of Illinois Chicago
-
Dean of the Sol Price School of Public Policy; Distinguished Professor of Pharmacy, Public Policy, and Economics, University of Southern California
-
Professor, Department of Health Policy, London School of Economics and Political Science
-
Senior Lecturer, University of Sydney, University of Sydney
-
Lecturer, Public Sector Finance, University of Canberra
